NCT05463094View on ClinicalTrials.gov

GXR RM China BE Study (Darmstadt - Jiangsu)

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 25, 2022

Primary Completion Date

January 3, 2023

Study Completion Date

January 3, 2023

Conditions
Healthy
Interventions
DRUG

Test Glucophage® XR

Participants will receive single oral dose of Test GXR RM tablet under fasted or fed conditions.

DRUG

Reference Glucophage® XR

Participants will receive single oral dose of Reference GXR RM tablet under fasted or fed conditions.

Trial Locations (1)

Unknown

Research Site, Darmstadt

All Listed Sponsors
lead

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

INDUSTRY